COM:XBIOTECH
XBiotech
- Stock
Last Close
6.62
22/11 21:00
Market Cap
208.20M
Beta: -
Volume Today
37.41K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -3.29M - | -7.76M 136.19% | -4.48M 42.34% | |||||||||
average payables | 509K - | 1.09M 115.13% | 3.23M 194.70% | 4.63M 43.41% | 3.08M 33.44% | 1.69M 45.09% | 1.90M 12.39% | 2.32M 22.04% | 2.28M 1.72% | 2.24M 1.82% | 2.46M 9.98% | |
average receivables | 5.34M - | 9.82M 83.77% | 5.36M 45.43% | 1.31M 75.52% | ||||||||
book value per share | 0.32 - | 1.86 477.14% | 3.35 79.76% | 1.82 45.52% | 1.73 5.36% | 1.16 32.97% | 19.40 1,578.06% | 11.31 41.70% | 8.97 20.73% | 7.90 11.92% | 7.19 8.96% | |
capex per share | -0.00 - | -0.04 2,267.80% | -0.34 665.97% | -0.43 27.27% | -0.04 90.62% | -0.00 91.54% | -0.01 53.73% | -0.12 2,208.37% | -0.12 2.96% | -0.02 83.62% | -0.01 38.12% | |
capex to depreciation | -0.08 - | -2.10 2,695.71% | -14.87 606.63% | -19.93 34.08% | -0.95 95.25% | -0.05 94.70% | -0.09 72.31% | -1.67 1,827.37% | -1.33 20.06% | -0.22 83.19% | -0.21 7.25% | |
capex to operating cash flow | 0.01 - | 0.12 1,702.76% | 0.31 161.30% | 0.30 3.08% | 0.04 86.19% | 0.01 82.33% | 0.01 51.35% | 0.06 412.34% | -0.05 188.73% | 0.04 177.74% | 0.02 51.01% | |
capex to revenue | -0.08 - | -0.19 126.23% | -0.15 23.87% | |||||||||
cash per share | 0.23 - | 1.81 691.40% | 2.96 63.54% | 1.06 64.17% | 0.91 14.01% | 0.44 51.48% | 18.35 4,051.92% | 7.70 58.03% | 7.89 2.43% | 7.14 9.42% | 6.57 8.02% | |
days of inventory on hand | -69.45 - | -561.49 708.42% | ||||||||||
days payables outstanding | 26.32 - | 129.76 393.05% | 1.35K 940.49% | |||||||||
days sales outstanding | 88.66 - | 177.66 100.38% | 160.56 9.62% | |||||||||
debt to assets | ||||||||||||
debt to equity | ||||||||||||
dividend yield | 0.22 - | |||||||||||
earnings yield | -0.01 - | -0.03 118.84% | -0.11 280.01% | -0.16 43.72% | -0.24 49.94% | -0.12 51.83% | 0.92 891.47% | -0.02 102.53% | -0.05 123.88% | -0.31 491.29% | -0.20 34.50% | |
enterprise value | 730.17M - | 680.08M 6.86% | 243.77M 64.16% | 293.60M 20.44% | 105.64M 64.02% | 166.06M 57.19% | 12.32M 92.58% | 245.02M 1,888.30% | 97.40M 60.25% | -50.46M 151.81% | -78.27M 55.10% | |
enterprise value over ebitda | -79.90 - | -32.13 59.79% | -6.62 79.39% | -5.64 14.75% | -3.19 43.50% | -9.22 189.11% | -0.44 95.22% | -12.54 2,748.39% | -4.48 64.25% | 1.74 138.71% | 2.09 20.23% | |
ev to operating cash flow | -81.97 - | -58.13 29.09% | -7.32 87.41% | -6.38 12.82% | -3.14 50.79% | -10.04 219.85% | -0.67 93.28% | -3.76 457.59% | 1.40 137.29% | 3.40 142.72% | 4.18 22.79% | |
ev to sales | 5.57 - | 5.30 4.92% | -12.58 337.66% | |||||||||
free cash flow per share | -0.28 - | -0.41 46.06% | -1.42 243.57% | -1.85 30.36% | -1.01 45.65% | -0.47 53.71% | -0.47 1.95% | -2.23 371.07% | 2.19 198.19% | -0.51 123.07% | -0.63 23.87% | |
free cash flow yield | -0.01 - | -0.02 46.06% | -0.13 634.87% | -0.18 40.02% | -0.26 39.59% | -0.09 64.10% | -0.03 72.25% | -0.14 461.82% | 0.20 238.07% | -0.14 173.16% | -0.16 8.70% | |
graham net net | 0.20 - | 1.71 746.73% | 2.75 61.05% | 0.81 70.46% | 0.83 2.15% | 0.36 56.69% | 16.78 4,564.90% | 7.69 54.17% | 7.77 1.06% | 7.00 9.90% | 6.34 9.48% | |
graham number | 1.51 - | 5.36 255.39% | 9.57 78.71% | 8.17 14.62% | 6.07 25.67% | 3.92 35.48% | 86.57 2,109.04% | 9.63 88.88% | 10.81 12.35% | 13.86 28.16% | 11.42 17.57% | |
income quality | 0.90 - | 0.54 39.98% | 0.89 64.99% | 0.87 1.85% | 1.02 16.39% | 0.78 22.93% | -0.03 103.49% | 5.81 21,348.23% | -3.99 168.69% | 0.45 111.30% | 0.76 69.23% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 38.24 - | |||||||||||
interest debt per share | -0.03 - | |||||||||||
inventory turnover | -5.26 - | -0.65 87.63% | ||||||||||
invested capital | ||||||||||||
market cap | 737.41M - | 737.41M 0% | 334.82M 54.60% | 327.92M 2.06% | 137.41M 58.10% | 181.89M 32.37% | 726.92M 299.66% | 482.39M 33.64% | 334.38M 30.68% | 106.84M 68.05% | 121.75M 13.96% | |
net current asset value | 6.85M - | 54.92M 701.94% | 86.73M 57.93% | 28.94M 66.63% | 30.52M 5.45% | 14.07M 53.91% | 655.02M 4,555.75% | 320.77M 51.03% | 241.08M 24.84% | 214.14M 11.17% | 193.95M 9.43% | |
net debt to ebitda | 0.79 - | 2.71 241.65% | 2.47 8.69% | 0.66 73.32% | 0.96 45.32% | 0.88 8.39% | 25.54 2,807.01% | 12.15 52.41% | 10.91 10.22% | 5.41 50.41% | 5.33 1.44% | |
net income per share | -0.31 - | -0.68 118.84% | -1.22 77.67% | -1.63 33.80% | -0.95 41.62% | -0.59 37.89% | 17.17 3,008.03% | -0.36 102.12% | -0.58 59.22% | -1.08 86.47% | -0.81 25.36% | |
operating cash flow per share | -0.28 - | -0.37 31.34% | -1.08 193.14% | -1.42 31.32% | -0.96 32.06% | -0.46 52.13% | -0.47 1.57% | -2.11 350.55% | 2.31 209.36% | -0.49 121.07% | -0.62 26.32% | |
payables turnover | 13.87 - | 2.81 79.72% | 0.27 90.39% | |||||||||
receivables turnover | 4.12 - | 2.05 50.10% | 2.27 10.65% | |||||||||
research and ddevelopement to revenue | 0.22 - | 1.54 609.72% | 7.87 411.86% | |||||||||
return on tangible assets | -0.90 - | -0.35 61.03% | -0.34 1.90% | -0.79 129.58% | -0.53 33.10% | -0.48 9.45% | 0.82 271.72% | -0.03 103.88% | -0.06 99.50% | -0.13 111.25% | -0.11 18.94% | |
revenue per share | 1.43 - | 0.61 57.11% | 0.13 78.48% | |||||||||
roe | -0.97 - | -0.37 62.08% | -0.36 1.16% | -0.89 145.59% | -0.55 38.32% | -0.51 7.33% | 0.88 273.30% | -0.03 103.64% | -0.06 100.85% | -0.14 111.71% | -0.11 18.01% | |
roic | -0.97 - | -0.37 62.08% | -0.36 1.11% | -0.89 145.45% | -0.55 38.36% | -0.50 8.52% | -0.04 92.36% | -0.05 19.21% | -0.06 38.88% | -0.14 120.65% | -0.17 20.74% | |
sales general and administrative to revenue | 0.41 - | 0.51 23.39% | 1.57 208.07% | |||||||||
shareholders equity per share | 0.32 - | 1.86 477.14% | 3.35 79.76% | 1.82 45.52% | 1.73 5.36% | 1.16 32.97% | 19.40 1,578.06% | 11.31 41.70% | 8.97 20.73% | 7.90 11.92% | 7.19 8.96% | |
stock based compensation to revenue | 0.29 - | 0.24 15.15% | 1.26 420.27% | |||||||||
tangible asset value | 10.23M - | 59.03M 477.14% | 103.05M 74.57% | 59.06M 42.68% | 60.16M 1.86% | 41.40M 31.19% | 755.63M 1,725.28% | 348.64M 53.86% | 269.38M 22.73% | 240.40M 10.76% | 218.85M 8.97% | |
tangible book value per share | 0.32 - | 1.86 477.14% | 3.35 79.76% | 1.82 45.52% | 1.73 5.36% | 1.16 32.97% | 19.40 1,578.06% | 11.31 41.70% | 8.97 20.73% | 7.90 11.92% | 7.19 8.96% | |
working capital | 6.85M - | 54.92M 701.94% | 86.75M 57.97% | 28.97M 66.61% | 30.54M 5.43% | 14.07M 53.92% | 656.07M 4,562.26% | 321.89M 50.94% | 243.42M 24.38% | 215.78M 11.35% | 195.62M 9.34% |
All numbers in (except ratios and percentages)